… -200c in cancer tissues or in blood circulation can be used as a biomarker. Importantly, how
the level of miR-200c can be used to predict the effectiveness of the cancer therapy is also …

MicroRNAs (miRNAs) are proposed as a family of short noncoding molecules able to
manage and control the expression of the gene targets at the posttranscriptional level. They …

… of new disease biomarkers and therapeutic targets. … We then highlight promising
epigenetic biomarkers that, after … ), we deem to have the greatest potential for rapid bench-to-bedside …

… therapeutic potentials of miR-638 and discussed its mechanistic roles in various types of
cancers… miRNAs may serve as potential diagnostic and prognostic biomarkers for CRC [60]. …

… However, based on the pathogenetic relationship between miR-30a and cancer in … as tumor
promising biomarker. Moreover, it would offer a therapeutic target for the treatment of cancer. …

… the therapeutic potential of direct and indirect PP2A targeting compounds, possibly in
combination with other anti-cancer drugs, in EC. Furthermore, we investigate the potential of the …

… might serve as a potential therapeutic target and promising biomarker in various tumors. In
… -29a and its potential application in the diagnosis, treatment and stages of carcinoma, which …

… also been studied as a cancer biomarker, however, the observed decrease in most cancer
patients does not seem to be cancer specific. Encouraging results from experimental work …

… draw a very promising picture of miRNAs as potential new biomarkers for chemoresistance
in GC with diagnostic and therapeutic potential. This would help to tailor cancer therapy more …

… stages of tumor development [55]. Therefore, there is a real therapeutic potential based on
… In conclusion, these studies indicate TRPV2 to be a promising target to treat prostate cancer …